Dermatol. praxi. 2012;6(1):16-19

Risk factors for tumor recurrences in basal cell carcinoma of the skin

MUDr.Vladimír Bartoš1, prof.MUDr.Katarína Adamicová, PhD.1,2, MUDr.Milada Kullová3, doc.MUDr.Martin Péč, PhD.4
1 Oddelenie patologickej anatómie FNsP v Žiline
2 Ústav patologickej anatómie Jesseniovej lekárskej fakulty a UNM v Martine
3 Dermatovenerologické oddelenie, FNsP v Žiline
4 Ústav lekárskej biológie Jesseniovej lekárskej fakulty v Martine

Tumor recurrences of cutaneous basal cell carcinoma (BCC) represent a relatively frequent and therapeutically often difficult phenomenon

in clinical practice. Although their reliable prediction is very limited on the basis of routine demographical, clinical and histopathological

parameters, some of them may indicate an increased likelihood of tumor relapse. In general, the risk factors for BCC recurrences can

by cathegorized into tumor-related parameters and patient-related parameters. The first group primarily includes anatomical location

and histological type of carcinoma, tumor size and the extent of its invasion, or the number of tumor lesions. The second group mostly

includes the form of therapy, surgical margins status in cases of the samples removed by surgical excision, asscociated comorbidity

and immunosupressive status of the affected persons. The authors of the article present the basic informations about these prognostical

parameters and about their importance for BCC recurrences prediction in a routine clinical practice.

Keywords: basal cell carcinoma, tumor recurrences

Published: March 20, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartoš V, Adamicová K, Kullová M, Péč M. Risk factors for tumor recurrences in basal cell carcinoma of the skin. Dermatol. praxi. 2012;6(1):16-19.
Download citation

References

  1. Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol 2006; 19: S127-S147. Go to original source... Go to PubMed...
  2. Vantuchová Y, Čuřík R. Hodnocení bazocelulárního karcinomu vzhledem k histologickému typu, věku, pohlaví a lokalizaci. Čes-slov Derm 2007; 82(3): 140-145.
  3. Kyrgidis A, Vahtsevanos S, Tzellos TG, et al. Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital. Eur J Dermatol 2010; 20(3): 276-282. Go to original source... Go to PubMed...
  4. Thomas J, McKiernan M, Rao GS. Basal cell carcinoma: how long a follow-up is needed? A surgical audit. Eur J Plast Surg, 1996; 19: 318-319. Go to original source...
  5. Lee, JS, Yi JH, Yun SK, et al. Clinicohistopathological study of recurrent basal cell carcinomas after surgical excision. Korean J Dermatol 2010; 48(6): 453-459.
  6. Bumpous JM, Padhya TA, Barnett SN. Basal cell carcinoma of the head and neck: identification of predictors of recurrence. Ear Nose Throat J, 2000; 79(3): 200-202, 204. Go to original source...
  7. Boulinquez S, Grison-Tabone C, Lamant L, et al. Histological evolution of reccurent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol, 2004; 151(3): 623-626. Go to original source... Go to PubMed...
  8. Pieh S, Kuchar A, Novak P, et al. Long term results after surgical basal cell carcinoma excision in the eyelid region. Br J Ophthalmol 1999; 83: 85-88. Go to original source... Go to PubMed...
  9. Silverman MK, Kopf AV, Bart RS, et al. Recurrence rates of treated basal cell carcinomas: Part 2: Curettage-Electrodesiccation. J Dermatol Surg Oncol 1991 b; 17(9): 720-726. Go to original source... Go to PubMed...
  10. Newmann JC, Leffell DJ. Correlation of embryonic fusion planes with the anatomical distribution of basal cell carcinoma. Dermatol Surg 2007; 33(8): 957-965. Go to original source... Go to PubMed...
  11. Elamin I, Zečević RD, Vojvodić D, et al. Cytokine concentrations in basal cell carcinomas of different histological types and localization. Acta Dermatoven APA, 2008; 17(2): 55-59.
  12. Santiago F, Serra, D, Vieira R, Figueiredio A. Incidence and factors associated with recurrence after incomplete excision of basal cell carcinomas: a study of 90 cases. J Eur Acad Dermatol Venereol, 2010; 24(12): 1421-1424. Go to original source... Go to PubMed...
  13. Zimmermann AC, Klauss V. Predictors of recurrent basalioma of the eyelids and periorbital region. Ophthalmologe 2001; 98(6): 555-559. Go to original source... Go to PubMed...
  14. Başer TN, Bulutoglu R, Barutcu AY, et al. Evaluation of basal cell carcinomas with positive surgical margins: A five year retrospective analysis. Turk J Cancer 2008; 38(1): 16-19.
  15. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. J Am Acad Dermatol, 1990; 23: 1118-1126. Go to original source... Go to PubMed...
  16. Zagrodnik B, Kempf W, Seifert B, et al. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and bcl-2. Cancer 2003; 98(12): 2708-2714. Go to original source... Go to PubMed...
  17. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 2003; 148(2): 195-202. Go to original source... Go to PubMed...
  18. Bartoš V, Pokorný D, Zacharová O, et al. Klinicko-patologické aspekty bazocelulárneho karcinómu kože s nekompletnou excíziou: porovnávacia štúdia. Derma 2011; 11(1): 3-9.
  19. Bogelund FS, Philipsen PA, Gniadecki R. Factors affecting the recurrence rate of basal cell carcinoma. Acta Derm Venereol 2007; 87(4): 330-334. Go to original source... Go to PubMed...
  20. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas: Part 1. Overview. J Dermatol Surg Oncol, 1991 a; 17(9): 713-718. Go to original source... Go to PubMed...
  21. Silverman MK, Kopf AV, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992 a; 18(6): 471-476. Go to original source... Go to PubMed...
  22. Silverman MK, Kopf, AV, Gladstein AH, et al. Recurrence rates of treated basal cell carcinomas: Part IV: X-ray therapy. J Dermatol Surg Oncol 1992 b; 18(7): 549-554. Go to original source... Go to PubMed...
  23. Bartos V, Pokorny D, Zacharova O, et al. Multiple occurrence of basal cell carcinoma of the skin: a comparative study. Acta Med Mart 2010; 10(3): 22-29.
  24. Staibano S, Lo Muzio L, Pannone G, et al. DNA ploidy and cyclin D1 expression in basal cell carcinoma of the haed and neck. Am J Clin Pathol 2001; 115: 805-813. Go to original source... Go to PubMed...
  25. Healy E, Angus B, Lawrence CM, Rees JL. Prognostic value of Ki67 antigen expression in basal cell carcinomas. Br J Dermatol 1995; 133(5): 737-741. Go to original source... Go to PubMed...
  26. Yerebakan O, Ciftçioglu MA, Akkaya BK & Yilmaz E. Prognostic value of Ki-67, CD31 and epidermal growth factor receptor expression in basal cell carcinoma. J. Dermatol, 2003; 30(1): 33-41. Go to PubMed...
  27. Janisson-Dargaud D, Durlach A, Lorenzato M, et al. Aneuploidy, but not Ki-67 or EGFR expression, is associated with recurrences in basal cell carcinoma. J Cutan Pathol 2008; 35(10): 916-921. Go to original source... Go to PubMed...
  28. Rowe DE, Carroll, RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15(3): 315-328. Go to original source... Go to PubMed...
  29. Smeets NW, Kuijpers DI, Nelemans P, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol 2004; 151(1): 141-147. Go to original source... Go to PubMed...
  30. Walker P, Hill D. Surgical treatment of basal cell carcinomas using standard postoperative histological assessment. Australas J Dermatol 2006; 47(1): 1-12. Go to original source... Go to PubMed...
  31. Ríos-Buceta L. Management of basal cell carcinomas with positive margins. Actas Dermosifiliogr 2007; 98(10): 679-687. Go to original source...
  32. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol, 2004; 140(8): 985-988. Go to original source... Go to PubMed...
  33. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48. Go to original source... Go to PubMed...




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.